UPA and LNG in emergency contraception: the information by EMA and the scientific evidences indicate a prevalent anti-implantation effect

References

• Trussel J, Rodriguez G, Ellertson C. New estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception. 1998;57:363–369.
   PubMed Web of Science ®Google Scholar
• Wilcox AJ, Baird DD, Dunson DB, et al. On the frequency of intercourse around ovulation: evidence for biological influences. Hum Reprod. 2004;19:1539–1543.
   PubMed Web of Science ®Google Scholar
• Dunson DB, Baird DD, Wilcox AJ, et al. Day-specific probabilities of clinical pregnancy based on two studies with imperfect measures of ovulation. Hum Reprod. 1999;14:1835–1839.
   PubMed Web of Science ®Google Scholar
• Behre HM, Kuhlage J, Gaβner C, et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod. 2000;15:2478–2482.
   PubMed Web of Science ®Google Scholar
• Fine P, Mathé H, Ginde S, et al. Ulipristal acetate taken 48–120 hours after intercourse for emergency contraception. Obstet Gynecol. 2010;115:257–263.
   PubMed Web of Science ®Google Scholar
• Stirling A, Glasier A. Estimating the efficacy of emergency contraception-how reliable are the data? Contraception. 2002;66:19–22.
   PubMed Web of Science ®Google Scholar
• Dye HM, Stanford JB, Alder SC, et al. Women and postfertilization effects of birth control: consistency of beliefs, intentions and reported use. BMC Womens Health. 2005;5:11.
   PubMedGoogle Scholar
• Lopez-del Burgo C, Lopez-de Fez CM, Osorio A, et al. Spanish women’s attitudes towards post-fertilization effects of birth control methods. Eur J Obstet Gynecol Reprod Biol. 2010;151:56–61.
   PubMed Web of Science ®Google Scholar
• Willetts SJ, MacDougall M, Cameron ST. A survey regarding acceptability of oral emergency contraception according to the posited mechanism of action. Contraception. 2017;96:81–88.
   PubMed Web of Science ®Google Scholar
• Rosato E, Farris M, Bastianelli C. Mechanism of action of ulipristal acetate for emergency contraception: a systematic review. Front Pharmacol. 2016;6:1–7.
   Web of Science ®Google Scholar
• World Health Organization (WHO) Media Center. Emergency contraception: fact sheet. 2018. [cited 2018 Feb]. Available from: http://www.who.int/, http://www.who.int/mediacentre/factsheets/fs244/en/
   Google Scholar
• Advisory Committee for Reproductive Health Drugs. Ulipristal acetate 30 mg tablet. Briefing materials. 2010. Available from: https://www.scribd.com/document/33172703/From-The-Advisory-Committee-for-Reproductive-Health-Drugs
   Google Scholar
• Watson Medical Communication. Highlights of Prescribing Information - Ella Tablet. 2010 Available from: http://www.accessdata.fda.gov/, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022474s000lbl.pdf
   Google Scholar
• European Medicines Agency (EMA). European Public Assessment Report (EPAR) on ellaOne. 2018. [updated 2018 Aug 31]. Available from: https://www.ema.europa.eu/documents/product-information/ellaone-epar-product-information_en.pdf
   Google Scholar
• International Federation of Gynecology & Obstetrics (FIGO) and International Consortium for Emergency Contraception (ICEC). How do Levonorgestrel-only emergency contraceptive pills (LNG ECPs) work to prevent pregnancy? 2012. Available from: http://www.cecinfo.org/, http://www.cecinfo.org/custom-content/uploads/2014/01/ICEC_MoA_Statement_3-28-12.pdf
   Google Scholar
• Cheng L, Che Y, Gulmezoglu A. Interventions for emergency contraception (review). Cochrane Collab. 2012;8:1–286.
   Google Scholar
• Piaggio G, Kapp N, von Hertzen H. Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception. 2011;84:35–43.
   PubMed Web of Science ®Google Scholar
• Marions L, Hultenby K, Lindell I, et al. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol. 2002;100:65–71.
   PubMed Web of Science ®Google Scholar
• Durand M, del Carmen Cravioto M, Raymond EG, et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception. 2001;64:227–234.
   PubMed Web of Science ®Google Scholar
• Hapangama D, Glasier AF, Baird DT. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle. Contraception. 2001;64:123–129.
   Google Scholar
• Okewole IA, Arowojolu AO, Odusoga OL, et al. Effect of single administration of levonorgestrel on the menstrual cycle. Contraception. 2007;75:372–377.
   PubMed Web of Science ®Google Scholar
• Durand M, Seppala M, Cravioto M, et al. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle. Contraception. 2005;71:451–457.
   PubMed Web of Science ®Google Scholar
• The European Society of Contraception and Reproductive Health. How do Levonorgestrel-only emergency contraceptive pills (LNG ECPs) work to prevent pregnancy? 2011. Available from: http://www.escrh.eu/about-esc/news/how-do-levonorgestrel
   Google Scholar
• Croxatto HB, Brache V, Pavez M, et al. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception. 2004;70:442–450.
   PubMed Web of Science ®Google Scholar
• Brache V, Cochon L, Jesam C, et al. Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture. Hum Reprod. 2010;25:2256–2263.
   PubMed Web of Science ®Google Scholar
• Massai MR, Forcelledo ML, Brache V, et al. Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study. Hum Reprod. 2007;22:434–439.
   PubMed Web of Science ®Google Scholar
• Brache V, Cochon L, Deniaud M, et al. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception. 2013;88:611–618.
   PubMed Web of Science ®Google Scholar
• Creinin M, Schlaff W, Archer DF, et al. Progestin receptor modulator for emergency contraception: a randomized control trial. Obstet Gynecol. 2006;108:1089–1097.
   PubMed Web of Science ®Google Scholar
• Novikova N, Weisberg E, Stanczyk FZ, et al. Effectiveness of levonorgestrel emergency contraception given before or after ovulation-a pilot study. Contraception. 2007;75:112–118.
   PubMed Web of Science ®Google Scholar
• Noé G, Croxatto HB, Salvatierra AM, et al. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception. 2011;84:486–492.
   PubMed Web of Science ®Google Scholar
• Noé G, Croxatto HB, Salvatierra AM, et al. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception. 2010;81:414–420.
   PubMed Web of Science ®Google Scholar
• Lalitkumar P, Lalitkumar S, Meng C, et al. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an In vitro endometrial three-dimensional cell culture model. Hum Reprod. 2007;22:3031–3037.
   PubMed Web of Science ®Google Scholar
• Meng C, Andersson K, Bentin-Ley U, et al. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model. Fertil Steril. 2009;91:256–264.
   PubMed Web of Science ®Google Scholar
• Mozzanega B. Da vita a vita: viaggio alla scoperta della riproduzione umana [Life from life: a journey to the discovery of human reproduction]. Rome: Società Editrice Universo-SEU; 2013. Chapter 10, La regolazione della capacità riproduttiva [The regulation of reproduction]; p. 201–203.
   Google Scholar
• Mozzanega B, Cosmi E. How do levonorgestrel-only emergency contraceptive pills prevent pregnancy? Some considerations. Gynecol Endocrinol. 2011;27:439–442.
   PubMed Web of Science ®Google Scholar
• Mozzanega B, Gizzo S, Di Gangi S, et al. Ulipristal acetate: critical review about endometrial and ovulatory effects in emergency contraception. Reprod Sci. 2014;21:678–685.
   PubMed Web of Science ®Google Scholar
• Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and metaanalysis. Lancet. 2010;375:555–562.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMA). CHMP Assessment Report on ellaOne - EMA/73099/2015. 2015. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/001027/WC500181904.pdf
   Google Scholar
• Gemzell-Danielsson K, Berger C, Lalitkumar PGL. Emergency contraception – mechanism of action. Contraception. 2013;87:300–308.
   PubMed Web of Science ®Google Scholar
• Lalitkumar PGL, Berger C, Gemzell-Danielsson K. Emergency contraception. Best Pract Res Clin Endocrinol Metab. 2013;27:91–101.
   PubMed Web of Science ®Google Scholar
• Moreau C, Trussell J. Results from pooled phase III studies of ulipristal acetate for emergency contraception. Contraception. 2012;86:673–680.
   PubMed Web of Science ®Google Scholar
• Lira-Albarrán S, Durand M, Larrea-Schiavon MF, et al. Ulipristal acetate administration at mid-cycle changes gene expression profiling of endometrial biopsies taken during the receptive period of the human menstrual cycle. Mol Cell Endocrinol. 2017;447:1–11.
   PubMed Web of Science ®Google Scholar
• Stratton P, Hartog B, Hajizadeh N, et al. A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women. Hum Reprod. 2000;15:1092–1099.
   PubMed Web of Science ®Google Scholar
• Stratton P, Levens ED, Hartog B, et al. Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril. 2010;93:2035–2041.
   PubMed Web of Science ®Google Scholar
• Passaro MD, Piquion J, Mullen N, et al. Luteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women. Hum Reprod. 2003;18:1820–1827.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Rabe T, Cheng L. Emergency contraception. Gynecol Endocrinol. 2013;29:1–14.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Berger C, Lalitkumar PG. Mechanisms of action of oral emergency contraception. Gynecol Endocrinol. 2014;30:685–687.
   PubMed Web of Science ®Google Scholar
• Blithe DL, Nieman LK, Blye RP, et al. Development of the selective progesterone receptor modulator CDB-2914 for clinical indications. Steroids. 2003;68:1013–1017.
   PubMed Web of Science ®Google Scholar
• Attardi BJ, Burgenson J, Hild SA, et al. In vitro anti progestational/anti glucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone. J Steroid Biochem Mol Biol. 2004;88:277–288.
   PubMed Web of Science ®Google Scholar
• Attardi BJ, Burgenson J, Hild SA, et al. CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914. Mol Cell Endocrinol. 2002;188:111–123.
   PubMed Web of Science ®Google Scholar
• Gainer EE, Ulmann A. Pharmacologic properties of CDB(VA)-2914. Steroids. 2003;68:1005–1011.
   PubMed Web of Science ®Google Scholar
• Whitaker LHR, Murray AA, Matthews R, et al. Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium. Hum Reprod. 2017;32:531–543.
   PubMed Web of Science ®Google Scholar
• Zumoffen C, Gómez EMD, Caillea AM, et al. Study of the effect of ulipristal acetate on human sperm ability to interact with tubal tissue and cumulus-oocyte-complexes. Contraception. 2017;95:586–591.
   PubMed Web of Science ®Google Scholar
• Munuce MJ, Zumoffen C, Cicaré J, et al. Effect of exposure to ulipristal acetate on sperm function. Eur J Contracept Reprod Health Care. 2012;17:428–437.
   PubMed Web of Science ®Google Scholar
• Berger C, Boggavarapu NR, Menezes J, et al. Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitroco-culture system. Hum Reprod. 2015;30:800–811.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMA). CHMP assessment report for Ellaone - EMEA/261787/2009. 2009. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001027/WC500023673.pdf
   Google Scholar
• Tarantal AF, Hendrickx AG, Matlin SA, et al. Effects of two antiprogestins on early pregnancy in the long-tailed macaque (macaca fascicularis). Contraception. 1996;54:107–115.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMA). Levonorgestrel and Ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight - EMA/631408/2014. 2014. Available from: http://www.ema.europa.eu/, http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Emergency_contraceptives_31/WC500176381.pdf
   Google Scholar
• Cheng L, Che Y, Gülmezoglu AM. Intervention for emergency contraception. Cochrane Database Syst Rev. 2012;8:CD001324.
   PubMed Web of Science ®Google Scholar
• Taneepanichskul S. Emergency contraception with mifepristone 10 mg in Thai women. J Med Assoc Thai. 2009;92:999–1002.
   PubMedGoogle Scholar
• Bodensteiner KJ. Emergency contraception and RU-486 (mifepristone): do bioethical discussions improve learning and retention? Adv Physiol Educ. 2012;36:34–41.
   PubMed Web of Science ®Google Scholar
• Glasier A. Emergency postcoital contraception. N Engl J Med. 1997;337:1058–1064.
   PubMed Web of Science ®Google Scholar
• Glasier A, Thong KJ, Dewar M, et al. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med. 1992;327:1041–1044.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Marions L. Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception. Hum Reprod Update. 2004;10:341–348.
   PubMed Web of Science ®Google Scholar
• Hapangama DK, Brown A, Glasier AF, et al. Feasibility of administering mifepristone as a once a month contraceptive pill. Hum Reprod. 2001;16:1145–1150.
   PubMed Web of Science ®Google Scholar
• Agarwal M, Das V, Agarwal A, et al. Evaluation of mifepristone as a once a month contraceptive pill. Am J Obstet Gynecol. 2009;200:e27–e29.
   PubMed Web of Science ®Google Scholar
• Croxatto HB. Mifepristone for luteal phase contraception. Contraception. 2003;68:483–488.
   PubMed Web of Science ®Google Scholar
• Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366:409–420.
   PubMed Web of Science ®Google Scholar
• Koskas M, Chabbert-Buffet N, Douvier S, et al. Role of medical treatment for symptomatic leiomyoma management in premenopausal women. J Gynecol Obstet Biol Reprod. 2011;40:858–874.
   PubMedGoogle Scholar
• Esteve JL, Acosta R, Pérez Y, et al. Treatment of uterine myoma with 5 or 10 mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial. Eur J Obstet Gynecol Reprod Biol. 2012;161:202–208.
   PubMed Web of Science ®Google Scholar
• Carbonell Esteve JL, Riverón AM, Cano M, et al. Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery. Int J Womens Health. 2012;4:75–84.
   PubMedGoogle Scholar
• Shoupe D, Mishell DR, Jr, Page MA, et al. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase. Am J Obstet Gynecol. 1987;157:1421–1426.
   PubMed Web of Science ®Google Scholar
• EMA/482522/2018. 2018. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Esmya_20/European_Commission_final_decision/WC500253487.pdf
   Google Scholar